{
  "trial_id": "NCT03875729",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration since diagnosis, baseline C-peptide levels, presence of T1D-related autoantibodies, presence of stable thyroid or celiac disease, history of infections (HIV, HBV, HCV), baseline HbA1c levels, body mass index (BMI), race/ethnicity, family history of diabetes.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Peak C-peptide at screening",
          "baseline C-peptide levels"
        ],
        [
          "Number of positive type 1 diabetes (T1D) autoantibodies",
          "presence of T1D-related autoantibodies"
        ],
        [
          "Race/Ethnicity",
          "race/ethnicity"
        ],
        [
          "Body mass index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Glycated hemoglobin (HbA1c)",
          "baseline HbA1c levels"
        ],
        [
          "Time from type 1 diabetes (T1D) diagnosis to randomization",
          "duration since diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment",
        "Age group at randomization",
        "History of diabetic ketoacidosis (DKA)",
        "Human leukocyte antigen (HLA) genotyping - DR3",
        "Human leukocyte antigen (HLA) genotyping - DR4",
        "Anti-glutamic acid decarboxylase 65 (GAD65) autoantibody",
        "Anti-islet antigen 2 (IA-2) autoantibody",
        "Anti-zinc transporter 8 (ZnT8) autoantibody",
        "Anti-insulin autoantibody",
        "Anti-islet cell cytoplasmic antibody (ICA)",
        "Height",
        "Weight",
        "Body mass index (BMI) z-score",
        "C-peptide area under concentration-time curve standardized by mixed meal tolerance test duration",
        "Insulin use"
      ],
      "remaining_candidate_features": [
        "presence of stable thyroid or celiac disease",
        "history of infections (HIV, HBV, HCV)",
        "family history of diabetes"
      ]
    },
    "processed-gen-response": "Age, gender, duration since diagnosis, baseline C-peptide levels, presence of T1D-related autoantibodies, presence of stable thyroid or celiac disease, history of infections (HIV, HBV, HCV), baseline HbA1c levels, body mass index (BMI), race/ethnicity, family history of diabetes."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline C-peptide levels, Presence of T1D-related autoantibodies, Body Mass Index, HbA1c, Insulin dose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Peak C-peptide at screening",
          "Baseline C-peptide levels"
        ],
        [
          "Number of positive type 1 diabetes (T1D) autoantibodies",
          "Presence of T1D-related autoantibodies"
        ],
        [
          "Body mass index (BMI)",
          "Body Mass Index"
        ],
        [
          "Glycated hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Insulin use",
          "Insulin dose"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Age group at randomization",
        "History of diabetic ketoacidosis (DKA)",
        "Human leukocyte antigen (HLA) genotyping - DR3",
        "Human leukocyte antigen (HLA) genotyping - DR4",
        "Anti-glutamic acid decarboxylase 65 (GAD65) autoantibody",
        "Anti-islet antigen 2 (IA-2) autoantibody",
        "Anti-zinc transporter 8 (ZnT8) autoantibody",
        "Anti-insulin autoantibody",
        "Anti-islet cell cytoplasmic antibody (ICA)",
        "Height",
        "Weight",
        "Body mass index (BMI) z-score",
        "C-peptide area under concentration-time curve standardized by mixed meal tolerance test duration",
        "Time from type 1 diabetes (T1D) diagnosis to randomization"
      ],
      "remaining_candidate_features": [
        "Duration of Diabetes"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, Baseline C-peptide levels, Presence of T1D-related autoantibodies, Body Mass Index, HbA1c, Insulin dose"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Peak Stimulated C-peptide, T1D-related Autoantibodies, BMI, Insulin Dose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Peak C-peptide at screening",
          "Peak Stimulated C-peptide"
        ],
        [
          "Number of positive type 1 diabetes (T1D) autoantibodies",
          "T1D-related Autoantibodies"
        ],
        [
          "Body mass index (BMI)",
          "BMI"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Age group at randomization",
        "History of diabetic ketoacidosis (DKA)",
        "Human leukocyte antigen (HLA) genotyping - DR3",
        "Human leukocyte antigen (HLA) genotyping - DR4",
        "Anti-glutamic acid decarboxylase 65 (GAD65) autoantibody",
        "Anti-islet antigen 2 (IA-2) autoantibody",
        "Anti-zinc transporter 8 (ZnT8) autoantibody",
        "Anti-insulin autoantibody",
        "Anti-islet cell cytoplasmic antibody (ICA)",
        "Height",
        "Weight",
        "Body mass index (BMI) z-score",
        "C-peptide area under concentration-time curve standardized by mixed meal tolerance test duration",
        "Insulin use",
        "Glycated hemoglobin (HbA1c)",
        "Time from type 1 diabetes (T1D) diagnosis to randomization"
      ],
      "remaining_candidate_features": [
        "Duration of Diabetes",
        "Insulin Dose."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, Peak Stimulated C-peptide, T1D-related Autoantibodies, BMI, Insulin Dose."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetes, peak stimulated C-peptide at screening, T1D-related autoantibody status, HbA1c, insulin dose, presence of thyroid or celiac disease, medical history, concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Body mass index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Peak C-peptide at screening",
          "peak stimulated C-peptide at screening"
        ],
        [
          "Number of positive type 1 diabetes (T1D) autoantibodies",
          "T1D-related autoantibody status"
        ],
        [
          "Glycated hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Insulin use",
          "insulin dose"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Age group at randomization",
        "History of diabetic ketoacidosis (DKA)",
        "Human leukocyte antigen (HLA) genotyping - DR3",
        "Human leukocyte antigen (HLA) genotyping - DR4",
        "Anti-glutamic acid decarboxylase 65 (GAD65) autoantibody",
        "Anti-islet antigen 2 (IA-2) autoantibody",
        "Anti-zinc transporter 8 (ZnT8) autoantibody",
        "Anti-insulin autoantibody",
        "Anti-islet cell cytoplasmic antibody (ICA)",
        "Height",
        "Weight",
        "Body mass index (BMI) z-score",
        "C-peptide area under concentration-time curve standardized by mixed meal tolerance test duration",
        "Time from type 1 diabetes (T1D) diagnosis to randomization"
      ],
      "remaining_candidate_features": [
        "duration of diabetes",
        "presence of thyroid or celiac disease",
        "medical history",
        "concomitant medications"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetes, peak stimulated C-peptide at screening, T1D-related autoantibody status, HbA1c, insulin dose, presence of thyroid or celiac disease, medical history, concomitant medications."
  }
}